Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + Behavioural Activation Therapy for Treatment-Resistant Depression
NCT07801703Phase 3Not yet recruiting
- Sponsor
- University of Ottawa Institute of Mental Health Research at The Royal
- Start
- Sep 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in treatment-resistant depression (TRD), sponsored by University of Ottawa Institute of Mental Health Research at The Royal. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT07801703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07801703.